Table of Contents Author Guidelines Submit a Manuscript
Journal of Chemistry
Volume 2017, Article ID 9387102, 15 pages
https://doi.org/10.1155/2017/9387102
Research Article

Synthesis, Molecular Docking Studies, and Antifungal Activity Evaluation of New Benzimidazole-Triazoles as Potential Lanosterol 14α-Demethylase Inhibitors

1Department of Analytical Chemistry, Faculty of Pharmacy, Anadolu University, 26470 Eskişehir, Turkey
2Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, 26470 Eskişehir, Turkey
3Doping and Narcotic Compounds Analysis Laboratory, Faculty of Pharmacy, Anadolu University, 26470 Eskişehir, Turkey
4Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Anadolu University, 26470 Eskişehir, Turkey
5Department of Environmental Engineering, Faculty of Engineering, Anadolu University, Eskişehir, Turkey

Correspondence should be addressed to Yusuf Özkay; rt.ude.ulodana@yakzoy

Received 8 August 2017; Accepted 9 October 2017; Published 12 December 2017

Academic Editor: Gabriel Navarrete-Vazquez

Copyright © 2017 Nafiz Öncü Can et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Tang, C. Zheng, J. Lv et al., “Synthesis and antifungal activities in vitro of novel pyrazino [2,1-a] isoquinolin derivatives,” Bioorganic & Medicinal Chemistry Letters, vol. 20, no. 3, pp. 979–982, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. W. Wang, C. Sheng, X. Che et al., “Design, synthesis, and antifungal activity of novel conformationally restricted triazole derivatives,” Archiv der Pharmazie, vol. 342, no. 12, pp. 732–739, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. H. A. Ghabbour, M. M. Qabeel, W. M. Eldehna, A. Al-Dhfyan, and H. A. Abdel-Aziz, “Design, synthesis, and molecular docking of 1-(1-(4-chlorophenyl)-2-(phenylsulfonyl)ethylidene)-2-phenylhydrazine as potent nonazole anticandidal agent,” Journal of Chemistry, vol. 2014, Article ID 154357, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Emami, T. Banipoulad, H. Irannejad et al., “Imidazolylchromanones containing alkyl side chain as lanosterol 14α-demethylase inhibitors: Synthesis, antifungal activity and docking study,” Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 29, no. 2, pp. 263–271, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. R. S. Kankate, P. S. Gide, and D. P. Belsare, “Design, synthesis and antifungal evaluation of novel benzimidazole tertiary amine type of fluconazole analogues,” Arabian Journal of Chemistry, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Ahmad, A. Khan, N. Manzoor, and L. A. Khan, “Evolution of ergosterol biosynthesis inhibitors as fungicidal against Candida,” Microbial Pathogenesis, vol. 48, no. 1, pp. 35–41, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Sheng, Z. Miao, H. Ji et al., “Three-dimensional model of lanosterol 14α-demethylase from Cryptococcus neoformans: Active-site characterization and insights into azole binding,” Antimicrobial Agents and Chemotherapy, vol. 53, no. 8, pp. 3487–3495, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. Q. Zhang, D. Li, P. Wei et al., “Structure-based rational screening of novel hit compounds with structural diversity for cytochrome P450 sterol 14α-demethylase from penicillium digitatum,” Journal of Chemical Information and Modeling, vol. 50, no. 2, pp. 317–325, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Jacob K, S. Ganguly, P. Kumar, R. Poddar, and A. Kumar, “Homology model, molecular dynamics simulation and novel pyrazole analogs design of Candida albicans CYP450 lanosterol 14 α-demethylase, a target enzyme for antifungal therapy,” Journal of Biomolecular Structure and Dynamics, vol. 35, no. 7, pp. 1446–1463, 2017. View at Publisher · View at Google Scholar · View at Scopus
  10. İ. S. Doğan, S. Saraç, S. Sari et al., “New azole derivatives showing antimicrobial effects and their mechanism of antifungal activity by molecular modeling studies,” European Journal of Medicinal Chemistry, vol. 130, pp. 124–138, 2017. View at Publisher · View at Google Scholar · View at Scopus
  11. K. K. Reddy, S. K. Singh, S. K. Tripathi, C. Selvaraj, and V. Suryanarayanan, “Shape and pharmacophore-based virtual screening to identify potential cytochrome P450 sterol 14α-demethylase inhibitors,” Journal of Receptors and Signal Transduction, vol. 33, no. 4, pp. 234–243, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Stana, D. C. Vodnar, R. Tamaian et al., “Design, synthesis and antifungal activity evaluation of new thiazolin-4-ones as potential lanosterol 14α-demethylase inhibitors,” International Journal of Molecular Sciences, vol. 18, no. 1, article no. 177, 2017. View at Publisher · View at Google Scholar · View at Scopus
  13. A. G. S. Warrilow, J. G. L. Mullins, C. M. Hull et al., “S279 point mutations in Candida albicans sterol 14-α demethylase (CYP51) reduce in vitro inhibition by fluconazole,” Antimicrobial Agents and Chemotherapy, vol. 56, no. 4, pp. 2099–2107, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. A. A. Sagatova, M. V. Keniya, R. K. Wilson, M. Sabherwal, J. D. A. Tyndall, and B. C. Monk, “Triazole resistance mediated by mutations of a conserved active site tyrosine in fungal lanosterol 14α-demethylase,” Scientific Reports, vol. 6, Article ID 26213, pp. 1–6, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Sheng, W. Zhang, M. Zhang et al., “Homology modeling of lanosterol 14α-demethylase of Candida albicans and Aspergillus fumigatus and insights into the enzyme-substrate interactions,” Journal of Biomolecular Structure and Dynamics, vol. 22, no. 1, pp. 91–99, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Jiang, J. Zhang, Y. Cao et al., “Synthesis, in vitro evaluation and molecular docking studies of new triazole derivatives as antifungal agents,” Bioorganic & Medicinal Chemistry Letters, vol. 21, no. 15, pp. 4471–4475, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. D. J. Sheehan, C. A. Hitchcock, and C. M. Sibley, “Current and emerging azole antifungal agents,” Clinical Microbiology Reviews, vol. 12, no. 1, pp. 40–79, 1999. View at Google Scholar · View at Scopus
  18. A. A.-M. Abdel-Hafez, “Benzimidazole condensed ring systems: New synthesis and antineoplastic activity of substituted 3,4-dihydro- and 1,2,3,4-tetrahydro-benzo[4,5]imidazo[1, 2-a]pyrimidine derivatives,” Archives of Pharmacal Research, vol. 30, no. 6, pp. 678–684, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. Z. Ateş-Alagöz, C. Kuş, and T. Çoban, “Synthesis and antioxidant properties of novel benzimidazoles containing substituted indole or 1,1,4,4-tetramethyl-1,2,3,4-tetrahydro-naphthalene fragments,” Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 20, no. 4, pp. 325–331, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. N. N. Gülerman, H. N. Doan, S. Rollas, C. Johansson, and C. Çelik, “Synthesis and structure elucidation of some new thioether derivatives of 1,2,4-triazoline-3-thiones and their antimicrobial activities,” II Farmaco, vol. 56, no. 12, pp. 953–958, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. F. Hernández-Luis, A. Hernández-Campos, R. Castillo et al., “Synthesis and biological activity of 2-(trifluoromethyl)-1H-benzimidazole derivatives against some protozoa and Trichinella spiralis,” European Journal of Medicinal Chemistry, vol. 45, no. 7, pp. 3135–3141, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. K. S. Jain, V. M. Khedkar, N. Arya, P. V. Rane, P. K. Chaskar, and E. C. Coutinho, “Design, synthesis & evaluation of condensed 2H-4-arylaminopyrimidines as novel antifungal agents,” European Journal of Medicinal Chemistry, vol. 77, pp. 166–175, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. H.-T. Le, I. B. Lemaire, A.-K. Gilbert et al., “Histogranin-like antinociceptive and anti-inflammatory derivatives of o-phenylenediamine and benzimidazole,” The Journal of Pharmacology and Experimental Therapeutics, vol. 309, no. 1, pp. 146–155, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. A. T. Mavrova, P. Denkova, Y. A. Tsenov, K. K. Anichina, and D. I. Vutchev, “Synthesis and antitrichinellosis activity of some bis(benzimidazol-2-yl)amines,” Bioorganic & Medicinal Chemistry, vol. 15, no. 18, pp. 6291–6297, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. J. R. Maxwell, A. C. Wasdahl, D. A. Wolfson, and V. I. Stenberg, “Synthesis of 5-aryl-2H-tetrazoles, 5-aryl-2H-tetrazole-2-acetic acids, and [(4-phenyl-5-aryl-4H-1,2,4-triazol-3-yl)thio]acetic acids as possible superoxide scavengers and antiinflammatory agents,” Journal of Medicinal Chemistry, vol. 27, no. 12, pp. 1565–1570, 1984. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Özkay, Y. Tunali, H. Karaca, and I. Işikdaǧ, “Antimicrobial activity and a SAR study of some novel benzimidazole derivatives bearing hydrazone moiety,” European Journal of Medicinal Chemistry, vol. 45, no. 8, pp. 3293–3298, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. H.-Z. Zhang, G. L. V. Damu, G.-X. Cai, and C.-H. Zhou, “Design, synthesis and antimicrobial evaluation of novel benzimidazole type of Fluconazole analogues and their synergistic effects with Chloromycin, Norfloxacin and Fluconazole,” European Journal of Medicinal Chemistry, vol. 64, pp. 329–344, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. G. L. V. Damu, Q. Wang, H. Zhang, Y. Zhang, J. Lv, and C. Zhou, “A series of naphthalimide azoles: design, synthesis and bioactive evaluation as potential antimicrobial agents,” Science China Chemistry, vol. 56, no. 7, pp. 952–969, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. EUCAST, Definitive Document EDef 7.1: Method for the Determination of Broth Dilution MICs of Antifungal Agents for Fermentative Yeasts.
  30. O. N. Breivik and J. L. Owades, “Yeast analysis, spectrophotometric semimicrodetermination of ergosterol in yeast,” Journal of Agricultural and Food Chemistry, vol. 5, no. 5, pp. 360–363, 1957. View at Publisher · View at Google Scholar · View at Scopus
  31. H. K. Gençer, U. A. Çevik, S. Levent et al., “New benzimidazole-1,2,4-triazole hybrid compounds: synthesis, anticandidal activity and cytotoxicity evaluation,” Molecules, vol. 22, no. 4, article 507, 507 pages, 2017. View at Publisher · View at Google Scholar · View at Scopus
  32. N. Ö. Can, D. Osmaniye, S. Levent et al., “Synthesis of new hydrazone derivatives for MAO enzymes inhibitory activity,” Molecules, vol. 22, no. 8, p. 1381, 2017. View at Publisher · View at Google Scholar
  33. Ü. Demir Özkay, Ö. D. Can, B. N. Sağlık et al., “Design, synthesis, and AChE inhibitory activity of new benzothiazole–piperazines,” Bioorganic & Medicinal Chemistry Letters, vol. 26, no. 22, pp. 5387–5394, 2016. View at Publisher · View at Google Scholar · View at Scopus
  34. B. N. Sağlık, S. Ilgın, and Y. Özkay, “Synthesis of new donepezil analogues and investigation of their effects on cholinesterase enzymes,” European Journal of Medicinal Chemistry, vol. 124, pp. 1026–1040, 2016. View at Publisher · View at Google Scholar · View at Scopus
  35. QikProp, Schrödinger, LLC, New York, NY, USA, 2016, version 4.8.
  36. L. M. Podust, T. L. Poulos, and M. R. Waterman, “Crystal structure of cytochrome P450 14α-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors,” in Proceedings of the National Academy of Sciences, vol. 98, pp. 3068–3073, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. Maestro, version 10.6, Schrödinger, LLC, New York, NY, USA, 2016.
  38. Schrödinger, LLC, New York, NY, USA, 2016.
  39. LigPrep, Schrödinger, LLC, New York, NY, USA, 2016, version 3.8.
  40. Glide, Schrödinger, LLC, New York, NY, USA, 2016, version 7.1.
  41. M. A. Malik, S. A. Al-Thabaiti, and M. A. Malik, “Synthesis, structure optimization and antifungal screening of novel tetrazole ring bearing acyl-hydrazones,” International Journal of Molecular Sciences, vol. 13, no. 9, pp. 10880–10898, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Dhingra and R. A. Cramer, “Regulation of sterol biosynthesis in the human fungal pathogen Aspergillus fumigatus: Opportunities for therapeutic development,” Frontiers in Microbiology, vol. 8, article no. 92, 2017. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Lupetti, R. Danesi, M. Campa, M. D. Tacca, and S. Kelly, “Molecular basis of resistance to azole antifungals,” Trends in Molecular Medicine, vol. 8, no. 2, pp. 76–81, 2002. View at Publisher · View at Google Scholar · View at Scopus
  44. J. A. Kramer, J. E. Sagartz, and D. L. Morris, “The application of discovery toxicology and pathology towards the design of safer pharmaceutical lead candidates,” Nature Reviews Drug Discovery, vol. 6, no. 8, pp. 636–649, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. International Organization for Standardization, Biological Evaluation of Medical Devices-Part 5: Tests for In Vitro cytotoxicity ISO-10993-5, 3rd edition, 2009.
  46. D. Butina, M. D. Segall, and K. Frankcombe, “Predicting ADME properties in silico: Methods and models,” Drug Discovery Therapy, vol. 7, no. 11, pp. S83–S88, 2002. View at Publisher · View at Google Scholar · View at Scopus
  47. C. A. Lipinski, F. Lombardo, B. W. Dominy, and P. J. Feeney, “Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings,” Advanced Drug Delivery Reviews, vol. 46, no. 1–3, pp. 3–26, 2001. View at Publisher · View at Google Scholar · View at Scopus
  48. W. L. Jorgensen and E. M. Duffy, “Prediction of drug solubility from structure,” Advanced Drug Delivery Reviews, vol. 54, no. 3, pp. 355–366, 2002. View at Publisher · View at Google Scholar · View at Scopus
  49. R. González-Chávez, R. Martínez, M. E. Torre-Bouscoulet, M. Gallo, and M. M. González-Chávez, “De novo design of non-coordinating indolones as potential inhibitors for lanosterol 14-α-demethylase (CYP51),” Chemical & Pharmaceutical Bulletin, vol. 62, no. 1, pp. 16–24, 2014. View at Publisher · View at Google Scholar · View at Scopus
  50. R. Gollapudy, S. Ajmani, and S. A. Kulkarni, “Modeling and interactions of aspergillus fumigatus lanosterol 14-α demethylase 'A' with azole antifungals,” Bioorganic & Medicinal Chemistry, vol. 12, no. 11, pp. 2937–2950, 2004. View at Publisher · View at Google Scholar · View at Scopus